George Kemble
Chair at Sagimet Biosciences Inc. (SGMT); Director at Sagimet Biosciences Inc. (SGMT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 17SEC | SGMTSagimet Biosciences Inc. | Sell Plan | 350,98762,161 held (−85%) | $10.23 | $3.6M | -21.6% |
| Aug 12SEC | SGMTSagimet Biosciences Inc. | Sell Plan | 20,20662,161 held (−25%) | $9.95 | $201K | -19.4% |
| Jul 22SEC | SGMTSagimet Biosciences Inc. | Sell Plan | 18,84462,161 held (−23%) | $7.46 | $141K | +7.5% |
| Nov 21SEC | SGMTSagimet Biosciences Inc. | Sell Plan | 37,68881,005 held (−32%) | $7.69 | $290K | +4.3% |
- Sell
Director George Kemble sold $3.6M of SGMT at $10.23 — cuts the stake by 85%; pre-scheduled 10b5-1 plan sale.
- Sell
Director George Kemble sold $201K of SGMT at $9.95 — pre-scheduled 10b5-1 plan sale.
- Sell
Director George Kemble sold $141K of SGMT at $7.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Chair George Kemble sold $290K of SGMT at $7.69 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.